What the new India guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The archive
Page 131 of 170 of this archive, newest first.
What a 25% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
VendorInvestigate result on a Tianjin tirzepatide lot lands 0.7 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What happens when the drug is taken away: three randomised answers
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
The badge economy, and what it is actually certifying
The Journal does not treat a badge as evidence and states so wherever it reports one.
Gauge, pain and flow rate
Gauge affects pain and flow rate rather than depth. A finer needle is more comfortable and slower, and with a viscous solution the difference is noticeable.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
France pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Wuxi export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
India declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
What a split-sample exercise can establish, and what it cannot
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
Ireland health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
From the floor in Hong Kong: 20 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The 27-day notice: how a compounding wind-down works in Denmark
The document is four pages. Three of them are about dates.
Lipohypertrophy, and the absorption it ruins
A rotation scheme that is too complicated will not be followed. We describe the simple ones that are.
The interventions with trial support, and the much longer list without
The intervention with the clearest evidence is the one nobody frames as an intervention: adjusting the dose.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A supplier suspends shipping to Mexico after 3 consecutive customs detentions
The route did not close because of a rule about peptides.
SURMOUNT-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
How a claim degrades between the bench and the listing
Every step between the laboratory report and the product page removes information, and the badge is the last step.
Collapse temperature, and the hour of the cycle where shelf life is lost
Lyophilisation does not stop degradation. It slows every pathway by removing the solvent that most of them require, and the residue of solvent that remains sets the rate.
A shortage listing ends. 10 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
From the floor in Shenzhen: 16 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
What a 36% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
What a 1 mL syringe does that a 0.3 mL syringe does not
The graduation interval differs between barrel sizes, and a 1 mL barrel is frequently marked in two-unit steps. Reading one as though it were marked in single units halves…
How a claim degrades between the bench and the listing
What a verification mark would have to carry to be checkable: a date, a lot, a method, a submitter and a link to the report.
What changed at FGP in July, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
PeptideMeter result on a Suzhou retatrutide lot lands 2.2 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.